(Q43896991)

English

Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study (English)

1 reference

Europe PubMed Central

27 November 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

author name string

C J A Punt

1

1 reference

Europe PubMed Central

27 November 2017

H J Keizer

2

1 reference

Europe PubMed Central

27 November 2017

J Douma

3

1 reference

Europe PubMed Central

27 November 2017

T Skovsgaard

4

1 reference

Europe PubMed Central

27 November 2017

J Schüller

5

1 reference

Europe PubMed Central

27 November 2017

E W Muller

6

1 reference

Europe PubMed Central

27 November 2017

C H H Ten Napel

7

1 reference

Europe PubMed Central

27 November 2017

J J Croles

8

1 reference

Europe PubMed Central

27 November 2017

H Lochs

9

1 reference

Europe PubMed Central

27 November 2017

J Zhang

10

1 reference

Europe PubMed Central

27 November 2017

L Hammershaimb

11

1 reference

Europe PubMed Central

27 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

27 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

27 November 2017

13

1 reference

Europe PubMed Central

27 November 2017

1

1 reference

Europe PubMed Central

27 November 2017

81-86

1 reference

Europe PubMed Central

27 November 2017

Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIO.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF045

21 January 2018

Identifiers

10.1093/ANNONC/MDF045

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43896991&oldid=2104224440"